The value of exosome-derived noncoding RNAs in colorectal cancer proliferation, metastasis, and clinical applications

Clin Transl Oncol. 2022 Dec;24(12):2305-2318. doi: 10.1007/s12094-022-02908-6. Epub 2022 Aug 3.

Abstract

Colorectal cancer (CRC) is the third most common cancer in the world today, and its incidence and mortality rates are increasing every year. The ease of proliferation and metastasis of CRC has long been an important reason for its high mortality rate. Exosomes serve as key mediators that mediate communication between tumor cells and various other cells. Non-coding RNAs (ncRNAs) have been shown to play a key role in apoptosis, immunosuppression and proliferation metastasis in cancer. ncRNAs are loaded on exosomes and initiate the onset of metastasis by promoting epithelial-mesenchymal transition (EMT) at the primary site of the tumor. Meanwhile, exosome-derived ncRNAs construct a pre-metastatic niche (PMN) for CRC metastasis by forming an inflammatory microenvironment in distant organs, immunosuppression, and promoting angiogenesis and remodeling of the extracellular matrix. Here, we summarize the specific mechanisms associated with exosome-derived ncRNAs promoting local invasion and metastasis in CRC. Finally, we focus on their value for clinical application in future CRC diagnosis and treatment.

Keywords: CRC; Clinical application; Exosome; Metastasis; ncRNAs.

Publication types

  • Review

MeSH terms

  • Cell Proliferation
  • Colorectal Neoplasms* / pathology
  • Epithelial-Mesenchymal Transition / genetics
  • Exosomes* / genetics
  • Exosomes* / pathology
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Neoplasm Metastasis / pathology
  • RNA, Untranslated / genetics
  • Tumor Microenvironment

Substances

  • RNA, Untranslated